A carregar...
4CPS-162 Infliximab serum concentrations, antibody formation and clinical response in psoriatic patients
BACKGROUND: A large variability in biopharmaceutical kinetics exists between patients and even within a patient over time. Also, adequate thorough concentrations are linked to response in psoriasis. Therapeutic drug monitoring of biopharmaceuticals (i.e. infliximab–IFX) together with clinical respon...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535484/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.253 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|